LOADING
Comparing AbbVie Inc (ABBV) and Pfizer Inc (PFE), both in the Health Care sector. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | ABBV | PFE |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $464.4B | $158.5B |
| P/E Ratio | 74.2 | 37.1 |
| Forward P/E | 16.4 | 9.7 |
| PEG Ratio | 0.54 | 12.89 |
| EPS | $3.54 | $0.75 |
| Revenue Growth (YoY) | 10.2% | 2.6% |
| Profit Margin | 9.8% | 6.8% |
| Return on Equity | 62.3% | 5.0% |
| Dividend Yield | 2.63% | 6.12% |
| Beta | 0.28 | 0.30 |
| 52-Week High | $269.39 | $29.21 |
| 52-Week Low | $189.40 | $22.57 |
| Volume | -- | -- |
AbbVie Inc is the larger company by market capitalization. Pfizer Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. AbbVie Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.